Oct. 26, 2023 – Firms advertising and marketing costly and unproven stem cell therapies are concentrating on sufferers with lengthy COVID – an usually debilitating situation that so far has no confirmed therapies, in accordance with a report printed right this moment.
Researchers recognized 38 direct-to-consumer companies promoting purported stem cell therapies to forestall and deal with the virus – 36 of which additionally declare to deal with post-COVID syndrome.
“There’s an necessary alternative right here for regulators to grasp there are nonetheless fairly quite a lot of companies making problematic promoting claims,” mentioned Leigh Turner, PhD, the primary writer of a examine on the problem and a bioethics professor on the College of California, Irvine Division of Well being, Society, and Conduct. “I do not assume that is going to go away anytime quickly. It must be a excessive precedence.”
Stem cells, generally known as the physique’s “grasp cells,” can generate new cell sorts – one thing no different cell within the physique can do. And whereas they’ve the potential to restore and regenerate cells, these therapies haven’t been permitted by regulatory our bodies and should not backed by convincing security and efficacy knowledge.
The FDA issued a warning in 2019 towards stem cell therapies to deal with COVID-19.
Of the 60 clinics operated by these companies, 24 are primarily based within the U.S. and 22 are in Mexico, with different clinics within the Cayman Islands, Guatemala, Malaysia, Panama, the Philippines, Poland, Spain, Thailand, Ukraine, and the United Arab Emirates.
“It was fascinating to me the extent to which these have been companies working within the U.S., not in far-flung locations,” Turner mentioned.
Based on the report, clinics cost wherever from $2,950 to $25,000 for stem cell merchandise.
Many individuals with lengthy COVID cope with signs corresponding to mind fog, excessive fatigue, and extreme complications that linger for months and even years. One in 10 folks with the virus will get post-COVID syndrome. The severity of the signs, and the shortage of therapies, make sufferers significantly weak to false claims, mentioned Kristin Englund, MD, an infectious illness specialist who runs the Cleveland Clinic’s reCOVer clinic for lengthy COVID sufferers.
Englund mentioned a number of sufferers have requested about stem cell therapies, and she or he warns them that there may very well be potential unwanted side effects with out a lot, if any, profit. Firms usually attempt to declare a medical profit with out scientific proof and with out being acknowledged by a regulatory company, she mentioned.
“Once you work with this inhabitants, you see how determined they will get to return to the lives they lived pre-COVID,” she mentioned. “A number of the sufferers we’re seeing, they have been happening 3 years with these signs. Presently, there isn’t any single prognosis, no single therapy, and that’s tremendously irritating for sufferers.”
Julia Moore Vogel, PhD, a computational biologist and researcher at Scripps Analysis, has seen this downside by each a affected person and scientist lens. Earlier than catching the virus in July 2020, the 38-year-old was a long-distance runner. Now, after coping with lengthy COVID for 3 years, she counts her steps so she does not get too drained.
And whereas she has tried potential low-risk therapies like dietary supplements – which did not work for her – she wouldn’t use stem cell therapies, given the shortage of strong analysis.
“I after all keep in mind, in class, stem cell therapies being one thing that was very a lot an space of curiosity,” she mentioned. “I’d simply actually need to see the info earlier than I may really feel assured about making an attempt it.”
Although the Nationwide Institutes of Well being has launched a number of medical trials centered on treating lengthy COVID, and the FDA has licensed a number of stem cell medical trials for lengthy COVID, there may be nonetheless a lot to study post-viral syndromes basically, mentioned Michael R. Jordan, MD, an infectious illness physician at Tufts College in Medford, MA.
“There are a variety of observational cohort research and medical trials in progress to evaluate numerous therapies for lengthy COVID,” he mentioned. “However what’s necessary is there isn’t any confirmed therapy at this level, and proposals are for sufferers to work with licensed certified and skilled well being care suppliers for symptom administration.”
